A drug desperately sought after by Brits still at high risk from Covid-19 has been proven to save lives - despite the Government refusing to fund it on the NHS.
A global review of Evusheld suggests it would be 86% effective at protecting half a million immunosuppressed Brits currently still shielding because vaccines do not work for them.
Birmingham University and King’s College London have reviewed 17 trials of antibody boosting treatments including 25,000 participants.
